Management of peripheral arterial disease in the elderly: focus on cilostazol
Travis M Falconer1, John W Eikelboom2, Graeme J Hankey3, Paul E Norman11School of Surgery, University of Western Australia, Fremantle Hospital, Western Australia; 2Department of Medicine, McMaster University, Hamilton, Canada; 3Department of Neurology, Royal Perth Hospital, School of Medicine and Ph...
Main Authors: | Travis M Falconer, John W Eikelboom, Graeme J Hankey, Paul E Norman |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-03-01
|
Series: | Clinical Interventions in Aging |
Online Access: | https://www.dovepress.com/management-of-peripheral-arterial-disease-in-the-elderly-focus-on-cilo-peer-reviewed-article-CIA |
Similar Items
-
Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease
by: Jung‐Joon Cha, et al.
Published: (2023-06-01) -
Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database
by: Jordi Real, et al.
Published: (2018-05-01) -
5. THE EFFECT OF CILOSTAZOL TO ARTERIAL STIFFNESS IN THE HYPERTENSIVE PATIENT
by: Jin Oh Na, et al.
Published: (2009-10-01) -
Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
by: Kuang-Yi Tseng, et al.
Published: (2023-03-01) -
Pharmacological Potential of Cilostazol for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2019-05-01)